Kevin Finney
FounderChairman, President and CEO at Autobahn Therapeutics, Inc.
San Diego Metropolitan Area
FoundedAutobahn Therapeutics, Inc.
About
Finney has held board and operating roles across a range of biotechnology companies, including executive chairman of Elsie Biotechnologies and TARIS Biomedical, vice chairman of Eirion Therapeutics, and managing director at SK BioVentures. He also served as president and chief operating officer of Abide Therapeutics and sits on the board of directors of Vaxart.
Chairman, President and CEO at Autobahn Therapeutics, Inc.
Intro paths
→
In turn, Kevin can intro founders to Autobahn Therapeutics, Inc.'s investors below.
Autobahn Therapeutics, Inc.'s investors · 6
ARCH Venture PartnersChicago · $50K – $250M checks · since 2024Canaan PartnersStamford · $500K – $20M checks · since 2024Monograph Capital PartnersLondon · since 2024Newpath PartnersBoston · $50K – $10M checks · since 2024Pfizer Venture Investments$5M – $20M checks · since 2024Samsara BioCapitalPalo Alto · since 2024
Experience
- Stealth Mode BiotechExecutive Chairman of the Boardcurrent2026 — presentCambridge, MA
- Autobahn Therapeutics, Inc.Chairman and CEOcurrent2019 — presentGreater San Diego Area
- Vaxart, Inc.Member Board of Directorscurrent2025 — present
- Eirion TherapeuticsVice Chairman of the Board2016 — 2026
- Elsie BiotechnologiesExecutive Chairman of the Board2021 — 2024
- TARIS Biomedical LLCExecutive Chairman of the Board2015 — 2019
- SK BioVenturesManaging Director2018 — 2019
- Abide TherapeuticsPresident and Chief Operating Officer2019Greater San Diego Area
- Zavante TherapeuticsChief Operating Officer2015 — 2018Greater San Diego Area
- Anterios Inc.Director Board of Directors2015 — 2016
- AllerganHead of Corporate Development2006 — 2015
- Proprius LLCHead of Corporate Development2005
- Prometheus Laboratories Inc., A Nestlé Health Science CompanySenior Director, Business and Commercial Analytics2003 — 2005
- Amylin PharmaceuticalsDirector, Commercial Analytics and Operations2000 — 2003
- Parke-Davis division of Warner-LambertSales and Marketing Management1990 — 2000
Education
- Pepperdine Graziadio Business SchoolMaster of Business Administration (MBA), Business1997 — 1998
- California State University, Long BeachBachelor of Arts (B.A.), Exercise Physiology1986 — 1990
Skills & more
Pharmaceutical Industry56Biotechnology41Oncology16Clinical Development12Commercialization36Medical Devices27Technology Transfer10Product Launch13Drug Development7Biopharmaceuticals29Lifesciences8Pharmaceutical Sales8
+12 more
Business DevelopmentBusiness StrategyCardiologyClinical TrialsCROCompetitive AnalysisCompetitive IntelligenceCorporate DevelopmentCross-functional Team LeadershipDermatologyStrategic PlanningStrategyLanguages English
From Kevin's professional profile.
Frequently asked questions
- Who is Kevin Finney?
- Finney has held board and operating roles across a range of biotechnology companies, including executive chairman of Elsie Biotechnologies and TARIS Biomedical, vice chairman of Eirion Therapeutics, and managing director at SK BioVentures. He also served as president and chief operating officer of Abide Therapeutics and sits on the board of directors of Vaxart.
- Where does Kevin Finney work?
- Kevin Finney is Chairman, President and CEO of Autobahn Therapeutics, Inc..
- What companies did Kevin Finney found?
- Kevin Finney founded Autobahn Therapeutics, Inc..
- Where did Kevin Finney go to school?
- Kevin Finney studied at Pepperdine Graziadio Business School (Master of Business Administration (MBA), Business); California State University, Long Beach (Bachelor of Arts (B.A.), Exercise Physiology).
Same school
Also attended Pepperdine Graziadio Business School31
Kenneth KellerAssociate at Marlin Equity PartnersMark FieldsInvestor at Alsop Louie PartnersHamlet YousefManaging Partner at IronGate Capital AdvisorsJessica PascoliniHead of Operations at BURNT ISLAND VENTURESNia PatelVice President at Electric Feel Ventures LlcJamie RiggsCo-Founder and General Partner at Driven
+ 25 more
Also attended California State University, Long Beach23
Costanza CariniInvestor at DN CapitalAndie ParedesTalent Network at Redpoint VenturesKatie GlennOperations & Administration at Ballistic VenturesTanya WesleyInvestor at TRANSFORMATION CAPITALSaed NashefFounding Partner at RAED VenturesSimran NathVenture Partner at Suncoast Ventures
+ 17 more
Shared employers
Also worked at Autobahn Therapeutics, Inc.2
Also worked at Vaxart, Inc.1
Also worked at Allergan20
Jim CaggianoChief Executive Officer, Evolve Biologics at Two Bear CapitalSean AinsworthBiotech CEO at FemHealth VenturesJai ParekhDigital Health Advisor at Excelerate Health VenturesPatrick WardPrincipal and Portfolio Manager at Western Technology InvestmentVipul RawalPartner at Elevar EquityAdriane BrownManaging Partner at Flying Fish Ventures
+ 14 more
